<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00520949</url>
  </required_header>
  <id_info>
    <org_study_id>609-Med</org_study_id>
    <nct_id>NCT00520949</nct_id>
  </id_info>
  <brief_title>Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection</brief_title>
  <acronym>QT-Hp</acronym>
  <official_title>Quadruple Therapy Using Esomeprazole, Colloidal Bismuth Subcitrate, Amoxicillin-Clavulanate, and Furazolidone in Patients Who Failed to Eradicate H. Pylori With Triple Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aga Khan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Triple therapy, a combination of proton pump inhibitor with two antibiotics, is the gold
      standard for anti-Helicobacter pylori treatment. Usual antibiotics are clarithromycin, and
      either amoxicillin or one of the nitroimidazoles (metronidazole). However, there is an
      increasing evidence of H. pylori resistance to classical triple therapy. Another reason for
      this failure being low patient compliance with treatment. A regimen useful in one
      geographical area may not be effective or practical in another area. The aim of this study
      was to eradicate H. pylori infection resistant to triple therapy, establish the efficacy and
      safety of a 14-day therapeutic regimen to eradicate of H. pylori in patients who have failed
      with the classical triple therapy (omeprazole, clarithromycin and amoxicillin) given for 14
      days.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Eradication of H. pylori infection resistant to triple therapy.</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety of the quadruple therapy</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">176</enrollment>
  <condition>Treatment of Helicobacter Pylori</condition>
  <arm_group>
    <arm_group_label>Quadruple Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Augmentin (Amoxicillin-clavulanic)</intervention_name>
    <description>Amoxicillin-clavulanic acid 1 gram b.i.d</description>
    <arm_group_label>Quadruple Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Furoxone (furazolidone)</intervention_name>
    <description>furazolidone 200 mg b.i.d</description>
    <arm_group_label>Quadruple Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cebes (colloidal bismuth subcitrate)</intervention_name>
    <description>colloidal bismuth subcitrate 240 mg b.i.d</description>
    <arm_group_label>Quadruple Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esso (esomeprazole)</intervention_name>
    <description>esomeprazole 40 mg b.i.d for 14 days</description>
    <arm_group_label>Quadruple Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent given by the patient

          -  Patients known to have H. pylori infection diagnosed by histopathology, rapid urease
             test and urea breath test

          -  Failure to respond to classical triple regime of amoxicillin 1gram, clarithromycin
             500mg and omeprazole 20mg twice a day for 10-14 days as documented by repeat urea
             breath test done one month after eradication therapy

        Exclusion Criteria:

          -  Evidence of any malignancy, gastric outlet syndrome, history of gastric surgery,
             chronic liver disease, severe chronic renal failure, or any major co-morbidity.

          -  known or suspected hypersensitivity to the medication used in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zaigham Abbas, FACG</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aga Khan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aga Khan University Hospital</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>74800</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2007</study_first_submitted>
  <study_first_submitted_qc>August 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2007</study_first_posted>
  <last_update_submitted>April 7, 2009</last_update_submitted>
  <last_update_submitted_qc>April 7, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Zaigham Abbas</name_title>
    <organization>The Aga Khan University Hospital</organization>
  </responsible_party>
  <keyword>H.pylori</keyword>
  <keyword>Triple therapy failure</keyword>
  <keyword>Quadruple therapy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
    <mesh_term>Bismuth tripotassium dicitrate</mesh_term>
    <mesh_term>Furazolidone</mesh_term>
    <mesh_term>Esomeprazole</mesh_term>
    <mesh_term>Bismuth</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>October 27, 2010</submitted>
    <returned>November 24, 2010</returned>
    <submitted>October 14, 2012</submitted>
    <returned>November 14, 2012</returned>
    <submitted>March 26, 2017</submitted>
    <returned>May 4, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

